SMC4 and central nervous system cancer: This study provides a new insight into the cofunction of SMC4 and the mechanism by which the TGF β/Smad pathway is hyperactivated in gliomas, indicating that SMC4 is a valuable prognostic factor and a potential therapeutic target in gliomas (41).